Viatris to Participate in the BofA Securities 2024 Health Care Conference
Get Alerts VTRS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3%
Revenue Growth %: +1.1%
Join SI Premium – FREE
Interested parties can access a live webcast of the event at investor.viatris.com. An archived version also will be available following the live event and can be accessed at the same location for a limited time.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-to-participate-in-the-bofa-securities-2024-health-care-conference-302135148.html
SOURCE Viatris Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sharpa Unveils Three Flagship Products: D01 Robot, W02 Dexterous Hand and AE01 Data Glove at IROS 2026
- TruTrade Introduces a New Era of Automated Trading for Retail Traders
- Missed BNB and Solana Before Their Breakouts? Apeing’s $0.00055 Presale Could Be the Next 1000x Crypto Story
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share